Marijuana on the Jobsite: A Positive Test vs. Impairment

Legal
Published

According to the U.S. Centers for Disease Control and Prevention, marijuana — or cannabis — is the most commonly-used federally illegal drug in the United States, with an estimated 48.2 million people using it in 2019.

Despite its recreational legalization in many states, employers are free to ban the use and possession of marijuana in the workplace and are not prohibited from disciplinary action against employees who are using marijuana during work hours or while using employer property. Moreover, an employer is not prohibited from taking employment action against an employee if the employee is impaired by cannabis while working.

How do I know if someone is impaired?

There currently is no legally or medically accepted definition of what constitutes “impairment” (or being “under the influence” of marijuana). Unlike alcohol testing, impairment by marijuana cannot be objectively measured by any scientifically proven methodology. Current testing does not identify intoxication, only the presence of marijuana metabolites or THC, the psychoactive ingredient in marijuana. There is also no dispositive and complete list of symptoms of impairment.

In some states employers may consider an employee to be impaired or under the influence of cannabis if the employer has a good faith belief that an employee manifests specific, articulable symptoms while working that decrease or lessen the employee’s performance or interfere with an employer’s obligation to provide a safe and healthy workplace, free from recognized hazards, as required by state and federal occupational safety and health laws. Signs of impairment while working (or on call) include, but are not limited to:

  • Changes in speech and demeanor
  • Impaired dexterity, agility and coordination
  • Irrational or unusual behavior
  • Negligence or carelessness when operating equipment or machinery
  • Disregard for the safety of the employee or others
  • Carelessness that results in any injury to the employee or to others
  • Involvement in any accident that results in serious damage to equipment or property

Only symptoms that provide objectively observable indications that the employee’s performance of the essential duties or tasks of their position are decreased or lessened may be cited and these symptoms do not provide definitive proof. Employers are cautioned that such symptoms may also be an indication that an employee has a disability protected by state or federal law.

Proof may require demonstrating one or more of the symptoms of being impaired by marijuana and testing positive for the presence of marijuana in the employee’s system at the time the symptom is demonstrated. While it may be possible to act without the confirmation of a positive test result, it has been suggested that it is risky to do so because the law also provides that the employee must be given “a reasonable opportunity to contest the basis of the determination.”

What cannot be cited by an employer as articulable symptoms of impairment?

Employers may not use drug testing as a basis for an articulable symptom of impairment. It is a widely recognized view that a marijuana-positive result by itself says virtually nothing about impairment at work. Marijuana can be detected in bodily fluids for up to 30 days and in hair for up to 90 days after use, long after the impairment effects have worn off (see National Institutes of Health: NCBI: Objective Testing: Urine and Other Drug Tests).

A best practice for employers who test current employees for marijuana is to define and explain “impairment” and being “under the influence.” They should establish a strong record of impairment independent of a marijuana-positive result. That would include thorough, contemporaneous documentation of the reasons employees are sent for a reasonable suspicion testing. It could include an accident investigation report that rules out non-drug-related causes where circumstances warrant that conclusion.

Employers are advised to consult outside counsel for help in revising policies and addressing new marijuana challenges in the workplace.

For more information on marijuana and its implications for the workplace visit the NAHB Construction Liability Resources page.

Subscribe to NAHBNow

Log in or create account to subscribe to notifications of new posts.

Log in to subscribe

Latest from NAHBNow

Economics
Aug 17, 2026
Affordability Pressures Keep Builder Confidence Low

Builder confidence in the market for newly built single-family homes inched up one point to 35 in August, according to the NAHB/Wells Fargo Housing Market Index (HMI) released today.

Regulations | Environmental Issues
Aug 14, 2026
Administration Acts on 3 Key NAHB Deregulatory Priorities

Two regulations will become effective under the Endangered Species Act (ESA) on Aug. 20, and a third final rule rescinding the ESA’s 45-year-old “harm” regulatory definition becomes effective next month.

View all

Latest Economic News

Economics
Aug 17, 2026
Consumer Credit Slowed in Q2

In the second quarter of 2026, consumer credit growth slowed over the quarter and was lower than a year ago. According to the Federal Reserve’s G.19 Consumer Credit Report, total outstanding U.S. consumer credit reached $5.17 trillion in the second quarter of 2026.

Economics
Aug 17, 2026
Affordability Pressures Keep Builder Confidence Low

Builder sentiment remains muted from economic and geopolitical uncertainty, elevated mortgage rates and rising construction costs.

Economics
Aug 14, 2026
Single-Family Permitting Declines Through June in Contrast to Multifamily

Single-family permitting activity continued to weaken through the first half of 2026, while multifamily permitting remained somewhat stronger compared with the same period last year.